Metagenomi Research Development from 2010 to 2026
| MGX Stock | 1.54 0.13 9.22% |
Research Development | First Reported 2010-12-31 | Previous Quarter 125.6 M | Current Value 71.8 M | Quarterly Volatility 41.8 M |
Check Metagenomi Common financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Metagenomi Common's main balance sheet or income statement drivers, such as Net Interest Income of 9.1 M, Interest Income of 9.3 M or Depreciation And Amortization of 3.2 M, as well as many indicators such as Price To Sales Ratio of 2.82, Dividend Yield of 0.0 or PTB Ratio of 0.54. Metagenomi financial statements analysis is a perfect complement when working with Metagenomi Common Valuation or Volatility modules.
Metagenomi | Research Development | Build AI portfolio with Metagenomi Stock |
The evolution of Research Development for Metagenomi Common Stock provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Metagenomi Common compares to historical norms and industry peers.
Latest Metagenomi Common's Research Development Growth Pattern
Below is the plot of the Research Development of Metagenomi Common Stock over the last few years. It is Metagenomi Common's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Metagenomi Common's overall financial position and show how it may be relating to other accounts over time.
| Research Development | 10 Years Trend |
|
Research Development |
| Timeline |
Metagenomi Research Development Regression Statistics
| Arithmetic Mean | 41,914,328 | |
| Geometric Mean | 27,278,948 | |
| Coefficient Of Variation | 99.76 | |
| Mean Deviation | 35,505,836 | |
| Median | 14,478,000 | |
| Standard Deviation | 41,815,623 | |
| Sample Variance | 1748.5T | |
| Range | 111.1M | |
| R-Value | 0.79 | |
| Mean Square Error | 688.2T | |
| R-Squared | 0.63 | |
| Significance | 0.0001 | |
| Slope | 6,577,825 | |
| Total Sum of Squares | 27976.7T |
Metagenomi Research Development History
About Metagenomi Common Financial Statements
Metagenomi Common investors use historical fundamental indicators, such as Metagenomi Common's Research Development, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Metagenomi Common. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Research Development | 125.6 M | 71.8 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Metagenomi Stock Analysis
When running Metagenomi Common's price analysis, check to measure Metagenomi Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Metagenomi Common is operating at the current time. Most of Metagenomi Common's value examination focuses on studying past and present price action to predict the probability of Metagenomi Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Metagenomi Common's price. Additionally, you may evaluate how the addition of Metagenomi Common to your portfolios can decrease your overall portfolio volatility.